Study on the molecular mechanism between lidocaine and cervical cancer cells found that lidocaine inhibits tumor growth by inhibiting cervical cancer cell viability and inducing apoptosis by regulating the lncRNA-MEG3/miR-421/BTG1 pathway, which provides a new direction for the clinical treatment of cervical cancer (Zhu and Han, 2019). This evidence concerns the gene MEG3 and cervical carcinoma.